|
MRA-47
|
Plasmodium vivax
|
yP.v.200 MSP1-19 2905/6
|
|
MRA-48
|
Plasmodium yoelii
|
yP.y.MSP1-19(XL)/VQ1
|
|
MRA-49
|
Plasmodium falciparum
|
yP30P2 PfMSP1-19 (E-TSR) 3D7/VK1
|
|
MRA-51
|
Plasmodium gallinaceum
|
yPgCSP-RPEU/VK1 pool-1
|
|
MRA-52
|
Plasmodium gallinaceum
|
yPgs28.1VK1
|
|
MRA-53
|
Plasmodium falciparum
|
yP30P2 PfMSP1-19(Q-KNG)FVO/VK1
|
|
MRA-55
|
Plasmodium falciparum
|
yPfMSP1-19(Q-TSR)VK1
|
|
MRA-56
|
Plasmodium falciparum
|
yPfMSP1-19(Q-KNG)VK1
|
|
MRA-57
|
Plasmodium falciparum
|
yPfs28c/VK1
|
|
MRA-58
|
Plasmodium falciparum
|
yPfMSP1-19(E-TSR)/VK1
|
|
MRA-59
|
Plasmodium falciparum
|
yRPEU-TBV25H/VK1
|
|
MRA-60
|
Plasmodium vivax
|
yP30P2-Pv200Msp1-19
|
|
MRA-86
|
Plasmodium falciparum
|
yPf39 recombinant proteins
|
|
MRA-768
|
Homo sapiens
|
Chondroitin Sulfate Proteoglycan (CSPG), human placental
|
|
MRA-769
|
Homo sapiens
|
Biotinylated Chondroitin Sulfate Proteoglycan (CSPG), human placental
|